Our results are consistent with, and extend, those obtained from microarray analysis by Schwartz et al (2002), who identified eEF1A2 as one of a group of genes that are highly expressed in clear cell carcinomas than other ovarian tumours. The gene discussed is EEF1A2; the disease is clear cell adenocarcinoma.